Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Antivert
See also: Meclizine
Meclizine is available in prescription strength (brand name Antivert®). It is uses in the prevention and treatment of symptoms of motion sickness; management of vertigo with diseases affecting the vestibular system
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Vertigo | 87 | 21 |
|
|
|
|
|
| Dizziness | 45 | 12 |
|
|
|
|
|
| Nausea | 8 | 3 |
|
|
|||
| Other | 8 | 1 |
|
||||
| Bad Vertigo with nausea | 4 | 1 |
|
||||
| Brain fog | 4 | 1 |
|
See all 129 patients currently taking Meclizine Prescription
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Meclizine Prescription
| Drowsiness | 3 | |
|---|---|---|
| Sudden onset of sleep after dose | 2 | |
| Sleepiness | 2 | |
| Fatigue | 1 | |
| Dry mouth at night | 1 | |
| Inability to drive due to medication | 1 | |
| See all 8 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Meclizine Prescription. See all 33 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 14 | ||
| Other | 13 | ||
| Did not seem to work | 10 | ||
| Doctor's advice | 4 | ||
| Side effects too severe | 1 | ||
| Expense | 1 | ||
| Not indicated | 1 |
See all 41 patients who’ve stopped taking Meclizine Prescription
Adherence
Taking treatment as prescribed
Adherence of Meclizine Prescription
Always |
25 | 69% |
|
|---|---|---|---|
Usually |
6 | 17% |
|
Sometimes |
5 | 14% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Meclizine Prescription
Very |
1 | 3% |
|
|---|---|---|---|
Somewhat |
1 | 3% |
|
A little |
5 | 14% |
|
Not at all |
29 | 81% |
|
Cost
Paid out of pocket
Cost of Meclizine Prescription
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
2 | 10% |
|
< $25 |
19 | 90% |
|
Report created on February 12, 2012.